Latest News

Cure SMA Publishes Article on SMA Clinical Trial Readiness Program in the U.S.

June 2, 2020
Posted in

    Cure SMA is proud to share with the SMA community that it has published a paper in the Orphanet Journal of Rare Diseases, titled ‘The SMA Clinical Trial […]

Read More ›

Registration Now Open for the 2020 Virtual SMA Conference

May 27, 2020
Posted in ,

Cure SMA has released the agenda and registration details for the 2020 Virtual SMA Conference, which will be held from Monday, June 8th – Friday, June 12th. We greatly look […]

Read More ›

Biogen Shares SPINRAZA Research Update

May 18, 2020
Posted in ,

New SPINRAZA® (nusinersen) Data Reinforce Sustained Efficacy and Longer-Term Safety Across Broad Range of SMA Patients Biogen Inc. recently announced additional data from the SPINRAZA (nusinersen) clinical development program that […]

Read More ›

Cure SMA Announces a 2020 Virtual SMA Conference – United, At Home

May 14, 2020
Posted in ,

Cure SMA has been hosting the Annual SMA Conference since 1988, bringing together leading researchers, clinicians, affected individuals, and families living with SMA. The weekend has traditionally been filled with […]

Read More ›

Cure SMA Announces Summit of Strength Virtual Webinar Series

May 14, 2020
Posted in ,

For the past two years, Cure SMA’s Summit of Strength program has brought together thousands of SMA community members for the opportunity to network and learn about the latest advances […]

Read More ›

Biogen Releases Q2 Community Statement on Latest Milestones in Clinical Development Program

May 11, 2020
Posted in ,

Dear Members of the SMA Community, In light of the COVID-19 pandemic and the burden it has placed on our healthcare system, Biogen is working with health systems, institutions, physicians, […]

Read More ›
Scroll to Top